Novartis is a major pharmaceutical company involved in space-based research and development. They send research experiments to the International Space Station (ISS) to study the effects of microgravity on biological processes, including muscle atrophy and bone regeneration. Novartis partners with organizations like Voyager Therapeutics and leverages the ISS National Lab to investigate accelerated models of disease and test new treatments. Their work aims to develop novel therapeutics for musculoskeletal diseases and other conditions, with potential benefits for patients on Earth.
All verified mentions of this organization in source documents.
Johannes Galatsanos previously served as Executive Director at Novartis, where he built data and AI products across manufacturing and R&D.